Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

OptiNose Inc (OPTN)

  • Technical Exchange News
  • Jan. 16, 2025, 18:39 UTC
  • 55
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

DURECT Corporation (DRRX)

  • Technical Exchange News
  • Jan. 16, 2025, 18:38 UTC
  • 55
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Vor Biopharma Inc (VOR)

  • Technical Exchange News
  • Jan. 16, 2025, 02:58 UTC
  • 50
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Ocean Biomedical Inc (OCEA)

  • Technical Exchange News
  • Jan. 16, 2025, 02:58 UTC
  • 52
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Deficient.

Comment Full text

Mainz Biomed (MYNZ)

  • Technical Exchange News
  • Jan. 16, 2025, 02:58 UTC
  • 52
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Vor Biopharma Inc (VOR)

  • Technical Exchange News
  • Jan. 15, 2025, 19:08 UTC
  • 54
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Ocean Biomedical Inc (OCEA)

  • Technical Exchange News
  • Jan. 15, 2025, 19:07 UTC
  • 57
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Deficient.

Comment Full text

Mainz Biomed (MYNZ)

  • Technical Exchange News
  • Jan. 15, 2025, 19:07 UTC
  • 62
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Syros Pharmaceuticals (SYRS)

  • Technical Exchange News
  • Jan. 15, 2025, 02:39 UTC
  • 52
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Syros Pharmaceuticals (SYRS)

  • Technical Exchange News
  • Jan. 14, 2025, 19:17 UTC
  • 51
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 331
  • 332
  • 333
  • 334
  • 335
  • Next

Search

News categories

  • Technical Exchange News(11448)
  • Event(3182)
  • SEC News(210990)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(136517)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin